Gall Stone Global Clinical Trials Review, H1, 2012

Summary

companys clinical trial report, “Gall Stone Global Clinical Trials Review, H1, 2012 provides data on the Gall Stone clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Gall Stone. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Gall Stone. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by companys team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

List of Tables 4
List of Figures 5
Introduction 6
Gall Stone 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by BRIC Nations 15
Clinical Trials by G7 Nations 16
Clinical Trials in G7 Nations by Trial Status 17
Clinical Trials by E7 Nations 18
Clinical Trials in E7 Nations by Trial Status 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Unaccomplished Trials of Gall Stone 23
Subjects Recruited Over a Period of Time 25
Prominent Sponsors 26
Top Companies Participating in Gall Stone Therapeutics Clinical Trials 28
Prominent Drug Comparison 29
Clinical Trial Profiles 30
Clinical Trial Overview of Top Companies 30
CATALYSIS, S.L. 30
Clinical Trial Overview of CATALYSIS, S.L. 30
Dr. Falk Pharma GmbH 31
Clinical Trial Overview of Dr. Falk Pharma GmbH 31
UMC Utrecht 32
Clinical Trial Overview of UMC Utrecht 32
Simbionix USA Corp. 33
Clinical Trial Overview of Simbionix USA Corp. 33
Intuitive Surgical, Inc. 34
Clinical Trial Overview of Intuitive Surgical, Inc. 34
USGI Medical, Inc. 35
Clinical Trial Overview of USGI Medical, Inc. 35
Clinical Trial Overview of Top Universities / Institutes / Hospitals 36
Mansoura University 36
Clinical Trial Overview of Mansoura University 36
University of California, San Diego 37
Clinical Trial Overview of University of California, San Diego 37
Sydney West Area Health Service 38
Clinical Trial Overview of Sydney West Area Health Service 38
Mayo Clinic 39
Clinical Trial Overview of Mayo Clinic 39
G. Hatzikosta General Hospital 40
Clinical Trial Overview of G. Hatzikosta General Hospital 40
Pamela Youde Nethersole Eastern Hospital 41
Clinical Trial Overview of Pamela Youde Nethersole Eastern Hospital 41
Horst Schmidt Klinik Wiesbaden 42
Clinical Trial Overview of Horst Schmidt Klinik Wiesbaden 42
Massachusetts General Hospital 43
Clinical Trial Overview of Massachusetts General Hospital 43
Maastricht University Medical Center 44
Clinical Trial Overview of Maastricht University Medical Center 44
University of California, San Francisco 45
Clinical Trial Overview of University of California, San Francisco 45
Baystate Medical Center 46
Clinical Trial Overview of Baystate Medical Center 46
Los Angeles Biomedical Research Institute 47
Clinical Trial Overview of Los Angeles Biomedical Research Institute 47
Catholic University of the Sacred Heart 48
Clinical Trial Overview of Catholic University of the Sacred Heart 48
Ege University 49
Clinical Trial Overview of Ege University 49
Tabriz University 50
Clinical Trial Overview of Tabriz University 50
Hvidovre University Hospital 51
Clinical Trial Overview of Hvidovre University Hospital 51
McGill University Health Center 52
Clinical Trial Overview of McGill University Health Center 52
The National Institute of Diabetes and Digestive and Kidney Diseases 53
Clinical Trial Overview of The National Institute of Diabetes and Digestive and Kidney Diseases 53
University of Thessaly 54
Clinical Trial Overview of University of Thessaly 54
Universidad Juarez Durango 55
Clinical Trial Overview of Universidad Juarez Durango 55
Five Key Clinical Profiles 56
Appendix 70
Abbreviations 70
Definitions 70
Research Methodology 71
Secondary Research 71
About company 72
Contact Us 72
Disclaimer 72
Source 73

List of Tables

Gall Stone Therapeutics Market, Global, Clinical Trials by Zone, 2012* 7
Gall Stone Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 8
Gall Stone Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 9
Gall Stone Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2012* 10
Gall Stone Therapeutics Clinical Trials, Europe, Top Five Countries, 2012* 11
Gall Stone Therapeutics Clinical Trials, North America, Top Countries, 2012* 12
Gall Stone Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2012* 13
Gall Stone Therapeutics Clinical Trials, Central and South America, Top Countries, 2012* 14
Gall Stone Therapeutics Clinical Trials, BRIC Countries, 2012* 15
Gall Stone Therapeutics Clinical Trials, G7 Countries, 2012* 16
Gall Stone Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 17
Gall Stone Therapeutics Clinical Trials, E7 Countries, 2012* 18
Gall Stone Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 19
Gall Stone Therapeutics Market, Global, Clinical Trials by Phase, 2012* 20
Gall Stone Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012* 21
Gall Stone Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 22
Gall Stone Therapeutics Market, Global, Withdrawn Clinical Trials, 2012* 23
Gall Stone Therapeutics Market, Global, Terminated Clinical Trials, 2012* 24
Gall Stone Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 25
Gall Stone Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 27
Gall Stone Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 28
Gall Stone Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 29
Gall Stone Therapeutics Clinical Trials Market, Global, Clinical Trials by CATALYSIS, S.L., 2012* 30
Gall Stone Therapeutics Clinical Trials Market, Global, Clinical Trials by Dr. Falk Pharma GmbH, 2012* 31
Gall Stone Therapeutics Clinical Trials Market, Global, Clinical Trials by UMC Utrecht, 2012* 32
Gall Stone Therapeutics Clinical Trials Market, Global, Clinical Trials by Simbionix USA Corp., 2012* 33
Gall Stone Therapeutics Clinical Trials Market, Global, Clinical Trials by Intuitive Surgical, Inc., 2012* 34
Gall Stone Therapeutics Clinical Trials Market, Global, Clinical Trials by USGI Medical, Inc., 2012* 35
Gall Stone Therapeutics Clinical Trials Market, Global, Clinical Trials by Mansoura University, 2012* 36
Gall Stone Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Diego, 2012* 37
Gall Stone Therapeutics Clinical Trials Market, Global, Clinical Trials by Sydney West Area Health Service, 2012* 38
Gall Stone Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2012* 39
Gall Stone Therapeutics Clinical Trials Market, Global, Clinical Trials by G. Hatzikosta General Hospital, 2012* 40
Gall Stone Therapeutics Clinical Trials Market, Global, Clinical Trials by Pamela Youde Nethersole Eastern Hospital, 2012* 41
Gall Stone Therapeutics Clinical Trials Market, Global, Clinical Trials by Horst Schmidt Klinik Wiesbaden, 2012* 42
Gall Stone Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2012* 43
Gall Stone Therapeutics Clinical Trials Market, Global, Clinical Trials by Maastricht University Medical Center, 2012* 44
Gall Stone Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Francisco, 2012* 45
Gall Stone Therapeutics Clinical Trials Market, Global, Clinical Trials by Baystate Medical Center, 2012* 46
Gall Stone Therapeutics Clinical Trials Market, Global, Clinical Trials by Los Angeles Biomedical Research Institute, 2012* 47
Gall Stone Therapeutics Clinical Trials Market, Global, Clinical Trials by Catholic University of the Sacred Heart, 2012* 48
Gall Stone Therapeutics Clinical Trials Market, Global, Clinical Trials by Ege University, 2012* 49
Gall Stone Therapeutics Clinical Trials Market, Global, Clinical Trials by Tabriz University, 2012* 50
Gall Stone Therapeutics Clinical Trials Market, Global, Clinical Trials by Hvidovre University Hospital, 2012* 51
Gall Stone Therapeutics Clinical Trials Market, Global, Clinical Trials by McGill University Health Center, 2012* 52
Gall Stone Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Diabetes and Digestive and Kidney Diseases, 2012* 53
Gall Stone Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Thessaly, 2012* 54
Gall Stone Therapeutics Clinical Trials Market, Global, Clinical Trials by Universidad Juarez Durango, 2012* 55

List of Figures

Gall Stone Therapeutics Market, Global, Clinical Trials by Zone (%), 2012* 7
Gall Stone Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 8
Gall Stone Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 9
Gall Stone Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2012* 10
Gall Stone Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2012* 11
Gall Stone Therapeutics Clinical Trials, North America, Top Countries (%), 2012* 12
Gall Stone Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2012* 13
Gall Stone Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2012* 14
Gall Stone Therapeutics Clinical Trials, BRIC Countries (%), 2012* 15
Gall Stone Therapeutics Clinical Trials, G7 Countries (%), 2012* 16
Gall Stone Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 17
Gall Stone Therapeutics Clinical Trials, E7 Countries (%), 2012* 18
Gall Stone Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 19
Gall Stone Therapeutics Market, Global, Clinical Trials by Phase (%), 2012* 20
Gall Stone Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012* 21
Gall Stone Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 22
Gall Stone Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 25
Gall Stone Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 26
Gall Stone Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 28
Gall Stone Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 29
company Methodology 71